Standards Worldwide
Standards Worldwide
Phone +49 30 58885700-07

Standard [CURRENT]

ASTM F 2024:2010

Standard Practice for X-ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings

Publication date
2010 reapproved: 2021
Original language
English
Pages
4
Note
The publisher recommends this document in lieu of the withdrawn document ASTM F 2024:2000 , for which no replacement is available.

from 65.30 EUR VAT included

from 61.03 EUR VAT excluded

Format and language options

PDF download
  • 65.30 EUR

Shipment (3-5 working days)
  • 72.60 EUR

Monitor with the Standards Ticker

This option is only available after login.
Easily subscribe: Save time and money now!

You can also subscribe to this document - together with other important standards in your industry. This makes your work easier and pays for itself after a short time.

Sparschwein_data
Subscription advantages
Sparschwein Vorteil 1_data

Important standards for your industry, regularly updated

Sparschwein Vorteil 2_data

Much cheaper than buying individually

Sparschwein Vorteil 3_data

Useful functions: Filters, version comparison and more

Publication date
2010 reapproved: 2021
Original language
English
Pages
4
Note
The publisher recommends this document in lieu of the withdrawn document ASTM F 2024:2000 , for which no replacement is available.
DOI
https://dx.doi.org/10.1520/F2024-10R21

Quick delivery via download or delivery service

Buy securely with a credit card or pay upon receipt of invoice

All transactions are encrypted

Short description
1.1 This practice is for the determination, by the Reference Intensity Ratio External Standard Method, of the percent by weight of the crystalline phases, hydroxyapatite (HA), beta-(whitlockite) tricalcium phosphate (β-TCP), and calcium oxide (CaO) in coatings deposited upon metallic substrates by plasma-spraying hydroxyapatite. 1.2 A major component in plasma-sprayed HA coatings other than HA is expected to be amorphous calcium phosphate (ACP). Crystalline components other than HA that may be present include alpha- and beta- (whitlockite) tricalcium phosphates, tetracalcium phosphate (TTCP), calcium oxide, and calcium pyrophosphates. Quantification of the minor crystalline components has proven to be very unreliable due to extreme overlap and confounding of X-ray diffraction peaks. Therefore, this practice addresses the quantification of only HA, β-TCP, and CaO. 1.3 This practice was developed for plasma-sprayed HA coatings with HA contents of at least 50 % of the total coating. It is recognized that the analysis of the crystalline components uses diffraction from regions of the pattern that also includes a small contribution from the amorphous component. However, within the limits of applicability of this practice, the effect of such interference is believed to be negligible. 1.4 The coating analyzed shall be produced and processed under equivalent manufacturing conditions to that on the device of interest. 1.5 This practice requires the use of monochromated copper Kα radiation and flat samples. 1.6 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.7 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ICS
25.220.99
DOI
https://dx.doi.org/10.1520/F2024-10R21
Loading recommended items...
Loading recommended items...
Loading recommended items...